Neogen Corp
NASDAQ:NEOG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Neogen Corp
Operating Income
Neogen Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Neogen Corp
NASDAQ:NEOG
|
Operating Income
-$38m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Operating Income
$260.5m
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Operating Income
$109.3m
|
CAGR 3-Years
57%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$628.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Operating Income
$310.8m
|
CAGR 3-Years
105%
|
CAGR 5-Years
73%
|
CAGR 10-Years
22%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Operating Income
$192.9m
|
CAGR 3-Years
29%
|
CAGR 5-Years
29%
|
CAGR 10-Years
18%
|
|
Neogen Corp
Glance View
Founded in 1982, Neogen Corp. has steadily carved out its niche at the intersection of food safety and animal health, positioning itself as a vital player in agricultural diagnostics. The company's journey began in Lansing, Michigan, where it initially focused on innovative solutions to meet the growing demands of food safety and quality testing. By developing rapid tests for detecting foodborne bacteria and allergens, Neogen tapped into a critical market, addressing the increasing concerns about food safety amidst a complex global supply chain. This foundation in diagnostics set the stage for the growth Neogen would see over the ensuing decades. As Neogen expanded, it strategically diversified its offerings, moving beyond food safety into the broader realm of animal health. This expansion was not merely about developing products; it was about advancing the means by which farms and food producers monitor and ensure the health of their livestock and crops. The company's profits flow from the sale of its diagnostic products, which help minimize risks associated with food contamination and animal diseases. By providing a suite of solutions, from DNA testing for genetic traits and diseases in cattle to disinfectants and rodenticides that maintain farm hygiene, Neogen creates value for its clients by increasing their operational efficiency and safeguarding public health. This strategic blend of food safety and animal health products places Neogen at the heart of modern agricultural and food production systems, where safety and efficiency are paramount.
See Also
What is Neogen Corp's Operating Income?
Operating Income
-38m
USD
Based on the financial report for Feb 28, 2026, Neogen Corp's Operating Income amounts to -38m USD.